Evaluation of efficacy (reduction of blood pressure) and safety( adverse events) of Benidipine, Amlodipine and Telmisartan anti- hypertensive drugs in Patients of Hypertension - A comparative study.
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2020/03/024384
- Lead Sponsor
- AIIMS Patna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Newly diagnosed hypertensive patient.
2)Age: >=30 years to < 60 years.
3)BMI: >18.5 to < 30 kg/m2.
4)Sex: Both.
5)Systolic Blood Pressure: >=140 to <=160 mmHg.
6)Diastolic Blood Pressure: >=90 to <100 mmHg.
1)Age: <30yrs to >=60yrs.
2)BMI: <18.5 to >30 kg/m2.
3)Patients diagnosed with secondary hypertension.
4)Patients with renal disease (serum creatinine >1.2).
5)Patients with any history of drug allergies with anti-hypertensive agents.
6)Patients on any other anti-hypertensive drugs (ACEI/DIURETICS/BETA-BLOCKERS).
7)Patients with liver diseases (ALT/AST < 40IU)
8)Patients with pre-existing pedal edema, hypoproteinemia, and Nephrotic syndrome.
9)Patients with any other chronic illness (Diabetes, Rheumatoid arthritis, Tuberculosis).
10)On long term NSAID and steroids.
11)Patients with unsound mind and drug addicts.
12)Pregnant and lactating women.
13)Patient not willing to give consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method